In Vitro Antiviral Screening for Henipaviruses at BSL4.Methods Mol Biol. 2023; 2682:93-102.MM
Abstract
In vitro screening for antivirals is an essential step in the development of effective treatments against new and emerging pathogens. Here, we describe a simple, cell-based screening assay for evaluating antiviral effectiveness against Hendra and Nipah live virus infection under BSL4 conditions.
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
37610576
Citation
Mungall, Bruce A.. "In Vitro Antiviral Screening for Henipaviruses at BSL4." Methods in Molecular Biology (Clifton, N.J.), vol. 2682, 2023, pp. 93-102.
Mungall BA. In Vitro Antiviral Screening for Henipaviruses at BSL4. Methods Mol Biol. 2023;2682:93-102.
Mungall, B. A. (2023). In Vitro Antiviral Screening for Henipaviruses at BSL4. Methods in Molecular Biology (Clifton, N.J.), 2682, 93-102. https://doi.org/10.1007/978-1-0716-3283-3_7
Mungall BA. In Vitro Antiviral Screening for Henipaviruses at BSL4. Methods Mol Biol. 2023;2682:93-102. PubMed PMID: 37610576.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - In Vitro Antiviral Screening for Henipaviruses at BSL4.
A1 - Mungall,Bruce A,
PY - 2023/8/24/medline
PY - 2023/8/23/pubmed
PY - 2023/8/23/entrez
KW - Antiviral screen
KW - Hendra virus
KW - Immunolabeling
KW - In vitro
KW - Nipah virus
SP - 93
EP - 102
JF - Methods in molecular biology (Clifton, N.J.)
JO - Methods Mol Biol
VL - 2682
N2 - In vitro screening for antivirals is an essential step in the development of effective treatments against new and emerging pathogens. Here, we describe a simple, cell-based screening assay for evaluating antiviral effectiveness against Hendra and Nipah live virus infection under BSL4 conditions.
SN - 1940-6029
UR - https://www.unboundmedicine.com/medline/citation/37610576/In_Vitro_Antiviral_Screening_for_Henipaviruses_at_BSL4_
DB - PRIME
DP - Unbound Medicine
ER -
